diabetes drug

Rising diabetes rates in children: Four things health execs should knowHere are four things MCOs should know about a new study focusing on young patients with diabetes.
Small Doses: News for Pharmacists
Small Doses: News for PharmacistsThis week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.
New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
FDA approves 2 injectable diabetes drugsTwo new diabetes drugs, both long-acting injectable insulin products, were simultaneously approved by FDA.
Top drivers of diabetes care costsHow much does diabetes cost the healthcare system and what's driving cost increases? Find out.
Applying telemedicine in diabetes care managementTelemedicine could improve diabetic patient outcomes, expand access, and provide better economic value for patients. Find out how.
Innovative diabetes cost-reduction strategies
Innovative diabetes cost-reduction strategiesHere are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.
Diabetes drug spending on the riseThe sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.
Strategies to reduce diabetes health management costsRob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients.
Reducing type 2 diabetes mortality: empagliflozin studyThe results of a large study of the impact of empagliflozin (Jardiance) on cardiovascular outcomes were recently published. Here are some key takeaways.